+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Qsymia"

Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 110 Pages
  • Global
From
Anti-obesity Medication Market - Product Thumbnail Image

Anti-obesity Medication Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
Anti-Obesity Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Mechanism Of Action; By Route Of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Anti-Obesity Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Mechanism Of Action; By Route Of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Global
From
Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 342 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Qsymia is a prescription anti-obesity drug developed by VIVUS, Inc. It is a combination of two active ingredients, phentermine and topiramate, which work together to reduce appetite and increase satiety. The drug is approved by the US Food and Drug Administration (FDA) for the treatment of obesity in adults. Qsymia is available in two dosage strengths, 3.75 mg/23 mg and 7.5 mg/46 mg. Qsymia is one of several anti-obesity drugs on the market. Other drugs include Belviq, Contrave, Saxenda, and Xenical. These drugs are used to help people lose weight and reduce the risk of obesity-related health problems. Companies in the Qsymia market include VIVUS, Inc., Arena Pharmaceuticals, Orexigen Therapeutics, Inc., and Eisai Co., Ltd. Show Less Read more